Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-13-032501)

Filing Details

Accession Number:: 0001181431-13-032501
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-06-04 17:02:18
Reporting Period:: 2013-05-31

Filing Date:: 2013-06-04
Accepted Time:: 2013-06-04 17:02:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1429260	Coronado Biosciences Inc	CNDO	Pharmaceutical Preparations (2834)	205157386

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1244154	Dale Ritter	C/O Coronado Biosciences, Inc. 24 New England Executive Park Burlington MA 01803	Svp & Chief Accounting Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001	Acquisiton	2013-05-31	1,503	$3.88	11,503	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Options to purchase Common Stock	$1.93		2021-05-16	120,000	120,000	Direct
Common Stock	Options to purchase Common Stock	$6.85		2022-02-22	30,000	30,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2021-05-16	120,000	120,000	Direct
2022-02-22	30,000	30,000	Direct

Footnotes

These shares were acquired under the Issuer's 2012 Employee Stock Purchase Plan.
One-third of the shares will vest on each of May 16, 2012, 2013 and 2014.
One-third of the shares will vest on each of February 22, 2013, 2014 and 2015.